Updates

EBERS at the ASEBIO Investor Day

The Spanish Association of Biocompanies (ASEBIO) organized in Madrid on the 26th of September an investor day, which put in contact international investors in the healthcare sector with Spanish companies. EBERS’ CEO, Pedro Moreo, participated in the event and held meetings with representatives of multiple venture capital funds, where he explained the progress of the project and the future commercialization and development plans for the company.

investorday web

Cy-Tech seminar in Beijing

EBERS participated last July 9 in a seminar held in Beijing by our distributor in China, Cy-Tech. Our CEO, Pedro Moreo, talked about the advantages of normothermic perfusion applied to organs for transplantation and introduced the last results obtained with EBERS’ technology in animal models. Around one hundred people assisted to the meeting.

Beijing2019 1 Beijing2019 2

EBERS in the HEALTH_LSR-Towards a new frontier: Engineering at the service of biomedicine.

EBERS participated last May 24th in the HEALTH_LSR meeting that was held at the "Centro de Investigación Médica Avanzada" in Pamplona. Our CTO was talking about the advantages of normothermic perfusion applied to organs for transplantation. Around one hundred people assisted to the meeting, in which specialists of differen areas of engineering discussed about the application of innovative engineering techniques in medicine.

Pamplona2019

 

EBERS at the TERMIS-EU 2019 conference in Rhodes

The normothermic preservation technology from EBERS was presented during the TERMIS-EU conference that took place on May 26-31 in Rhodes, Greece. The company was present with a stand in the commercial exhibition of the conference and, in addition, EBERS’ CEO presented participated with two posters in the scientific sessions of the conference.

Stand TERMIS   Póster 1 TERMIS Póster 2 TERMIS

EBERS at the EIC-EVONIK Corporate Day

EBERS’ CEO, Pedro Moreo, participated in the EIC-EVONIK Corporate Day that took place in the headquarters of Evonik in Essen on February 6, co-organized by the European Innovation Council and Evonik. It was a great opportunity to present the new organ preservation technology that EBERS is developing to representatives of the Health Care division and the corporate venture capital fund of Evonik and discuss about the technology and potential collaborations.

eic and evonik 35 eicsummit2
eicsummit4 eicsummit4